PYDRA-X
- Renal tubular acidosis (RTA) with calcium stones.
- Hypocitraturic calcium oxalate nephrolithiasis.
- Uric acid lithiasis with or without calcium stones.
PYDRA-X is indicated for the management of renal tubular acidosis.
PYDRA-X is indicated for the management of hypocitraturic calcium oxalate nephrolithiasis.
PYDRA-X is indicated for the management of uric acid lithiasis with or without calcium stones.
PYDRA-X is best & effective in the relief from kidney stone.
DOSAGE:
Objective: To restore normal urinary citrate (greater than 320mg/day and as close to the normal mean of 640mg/day as possible) and to increase urinary pH to a level of 6.0 to 7.0.
Severe hypocitraturia (urinary citrate < 150mg/day):
Therapy should be initiated at 60mEq/day; a dose of 30mEq 2 times per day or 20mEq 3 times per day with meals or within 30 minutes after meals or bed time snacks.
Mild to moderate hypocitraturia (urinary citrate > 150mg/day):
Therapy should be initiated at 30mEq/day; a dose of 15mEq 2 times per day or 10mEq 3 times per day with meals or within 30 minutes after meals or bed time snacks.
PRESENTATION:
2x10's tablets in Alu PVC Alu Pouch Blister Pack.
